MAIDSTONE, U.K. -- The Bedfont NObreath® is mentioned in new draft guidance recommending the use of simple, non-invasive testing to help diagnose and treat asthma (http://www.webmd.boots.com/asthma/default.htm). The report is produced by NICE, the National Institute for Health and Care Excellence.

There is further information regarding the guidelines in an article on the Boots Web MD website:- http://www.webmd.boots.com/asthma/news/20131108/nitric-oxide-test-asthma (http://www.webmd.boots.com/asthma/news/20131108/nitric-oxide-test-asthma)

Mr Jason Smith, Commercial Manager at Bedfont Scientific said “The NObreath® monitor enables doctors, asthma specialists, GP’s and respiratory specialists to comply with ATS and ERS guidelines when testing for FeNO levels in asthma patients. Asthma patients can easily be tested and correctly assessed, thus saving time and reducing costs.

The battery powered monitor has been specifically designed to be highly portable. A large graphical colour touch screen and rapid start-up allows easy use by people of all ages.”

For more information and clinical papers on the NObreath® please visit www.bedfont.com or call a member of our Sales Team on 01622 851122.


Contact
Niki Carter
01622 851122